Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Bispecific Antibodies Market, by Indication
1.4.2 Global Bispecific Antibodies Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Trials and Approvals
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Jun – 2022, Dec) Leading Players
Chapter 4. Global Bispecific Antibodies Market by Indication
4.1 Global Cancer Market by Region
4.2 Global Inflammatory & Autoimmune Disorder Market by Region
4.3 Global Others Market by Region
Chapter 5. Global Bispecific Antibodies Market by Region
5.1 North America Bispecific Antibodies Market
5.1.1 North America Bispecific Antibodies Market by Indication
5.1.1.1 North America Cancer Market by Country
5.1.1.2 North America Inflammatory & Autoimmune Disorder Market by Country
5.1.1.3 North America Others Market by Country
5.1.2 North America Bispecific Antibodies Market by Country
5.1.2.1 US Bispecific Antibodies Market
5.1.2.1.1 US Bispecific Antibodies Market by Indication
5.1.2.2 Canada Bispecific Antibodies Market
5.1.2.2.1 Canada Bispecific Antibodies Market by Indication
5.1.2.3 Mexico Bispecific Antibodies Market
5.1.2.3.1 Mexico Bispecific Antibodies Market by Indication
5.1.2.4 Rest of North America Bispecific Antibodies Market
5.1.2.4.1 Rest of North America Bispecific Antibodies Market by Indication
5.2 Europe Bispecific Antibodies Market
5.2.1 Europe Bispecific Antibodies Market by Indication
5.2.1.1 Europe Cancer Market by Country
5.2.1.2 Europe Inflammatory & Autoimmune Disorder Market by Country
5.2.1.3 Europe Others Market by Country
5.2.2 Europe Bispecific Antibodies Market by Country
5.2.2.1 Germany Bispecific Antibodies Market
5.2.2.1.1 Germany Bispecific Antibodies Market by Indication
5.2.2.2 UK Bispecific Antibodies Market
5.2.2.2.1 UK Bispecific Antibodies Market by Indication
5.2.2.3 France Bispecific Antibodies Market
5.2.2.3.1 France Bispecific Antibodies Market by Indication
5.2.2.4 Russia Bispecific Antibodies Market
5.2.2.4.1 Russia Bispecific Antibodies Market by Indication
5.2.2.5 Spain Bispecific Antibodies Market
5.2.2.5.1 Spain Bispecific Antibodies Market by Indication
5.2.2.6 Italy Bispecific Antibodies Market
5.2.2.6.1 Italy Bispecific Antibodies Market by Indication
5.2.2.7 Rest of Europe Bispecific Antibodies Market
5.2.2.7.1 Rest of Europe Bispecific Antibodies Market by Indication
5.3 Asia Pacific Bispecific Antibodies Market
5.3.1 Asia Pacific Bispecific Antibodies Market by Indication
5.3.1.1 Asia Pacific Cancer Market by Country
5.3.1.2 Asia Pacific Inflammatory & Autoimmune Disorder Market by Country
5.3.1.3 Asia Pacific Others Market by Country
5.3.2 Asia Pacific Bispecific Antibodies Market by Country
5.3.2.1 China Bispecific Antibodies Market
5.3.2.1.1 China Bispecific Antibodies Market by Indication
5.3.2.2 Japan Bispecific Antibodies Market
5.3.2.2.1 Japan Bispecific Antibodies Market by Indication
5.3.2.3 India Bispecific Antibodies Market
5.3.2.3.1 India Bispecific Antibodies Market by Indication
5.3.2.4 South Korea Bispecific Antibodies Market
5.3.2.4.1 South Korea Bispecific Antibodies Market by Indication
5.3.2.5 Singapore Bispecific Antibodies Market
5.3.2.5.1 Singapore Bispecific Antibodies Market by Indication
5.3.2.6 Malaysia Bispecific Antibodies Market
5.3.2.6.1 Malaysia Bispecific Antibodies Market by Indication
5.3.2.7 Rest of Asia Pacific Bispecific Antibodies Market
5.3.2.7.1 Rest of Asia Pacific Bispecific Antibodies Market by Indication
5.4 LAMEA Bispecific Antibodies Market
5.4.1 LAMEA Bispecific Antibodies Market by Indication
5.4.1.1 LAMEA Cancer Market by Country
5.4.1.2 LAMEA Inflammatory & Autoimmune Disorder Market by Country
5.4.1.3 LAMEA Others Market by Country
5.4.2 LAMEA Bispecific Antibodies Market by Country
5.4.2.1 Brazil Bispecific Antibodies Market
5.4.2.1.1 Brazil Bispecific Antibodies Market by Indication
5.4.2.2 Argentina Bispecific Antibodies Market
5.4.2.2.1 Argentina Bispecific Antibodies Market by Indication
5.4.2.3 UAE Bispecific Antibodies Market
5.4.2.3.1 UAE Bispecific Antibodies Market by Indication
5.4.2.4 Saudi Arabia Bispecific Antibodies Market
5.4.2.4.1 Saudi Arabia Bispecific Antibodies Market by Indication
5.4.2.5 South Africa Bispecific Antibodies Market
5.4.2.5.1 South Africa Bispecific Antibodies Market by Indication
5.4.2.6 Nigeria Bispecific Antibodies Market
5.4.2.6.1 Nigeria Bispecific Antibodies Market by Indication
5.4.2.7 Rest of LAMEA Bispecific Antibodies Market
5.4.2.7.1 Rest of LAMEA Bispecific Antibodies Market by Indication
Chapter 6. Company Profiles
6.1 Amgen, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Acquisition and Mergers:
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Trials and Approvals:
6.3 Pfizer, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional & Segmental Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.4 Akeso, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.5 Johnson & Johnson (Janssen Global Services, LLC)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental &Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Acquisition and Mergers:
6.6 Taisho Pharmaceuticals Holding Co., Ltd.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Immunocore Holdings plc
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.7.4 Recent strategies and developments:
6.7.4.1 Partnerships, Collaborations, and Agreements:
6.8 GlaxoSmithKline PLC (GSK)
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expense
6.9 Novartis AG
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.10. Allergan PLC (AbbVie, Inc.)
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expense



List of Figures

FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Jun – 2022, Dec) Leading Players
FIG 5 Global Bispecific Antibodies Market share by Indication, 2022
FIG 6 Global Bispecific Antibodies Market share by Indication, 2030
FIG 7 Global Bispecific Antibodies Market by Indication, 2019 - 2030, USD Million
FIG 8 Global Bispecific Antibodies Market share by Region, 2022
FIG 9 Global Bispecific Antibodies Market share by Region, 2030
FIG 10 Global Bispecific Antibodies Market by Region, 2019 - 2030, USD Million
FIG 11 Recent strategies and developments: Johnson & Johnson

List of Tables

TABLE 1 Global Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 2 Global Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Bispecific Antibodies Market
TABLE 4 Trials and Approvals – Bispecific Antibodies Market
TABLE 5 Acquisition and Mergers– Bispecific Antibodies Market
TABLE 6 Global Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 7 Global Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 8 Global Cancer Market by Region, 2019 - 2022, USD Million
TABLE 9 Global Cancer Market by Region, 2023 - 2030, USD Million
TABLE 10 Global Inflammatory & Autoimmune Disorder Market by Region, 2019 - 2022, USD Million
TABLE 11 Global Inflammatory & Autoimmune Disorder Market by Region, 2023 - 2030, USD Million
TABLE 12 Global Others Market by Region, 2019 - 2022, USD Million
TABLE 13 Global Others Market by Region, 2023 - 2030, USD Million
TABLE 14 Global Bispecific Antibodies Market by Region, 2019 - 2022, USD Million
TABLE 15 Global Bispecific Antibodies Market by Region, 2023 - 2030, USD Million
TABLE 16 North America Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 17 North America Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 18 North America Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 19 North America Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 20 North America Cancer Market by Country, 2019 - 2022, USD Million
TABLE 21 North America Cancer Market by Country, 2023 - 2030, USD Million
TABLE 22 North America Inflammatory & Autoimmune Disorder Market by Country, 2019 - 2022, USD Million
TABLE 23 North America Inflammatory & Autoimmune Disorder Market by Country, 2023 - 2030, USD Million
TABLE 24 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 25 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 26 North America Bispecific Antibodies Market by Country, 2019 - 2022, USD Million
TABLE 27 North America Bispecific Antibodies Market by Country, 2023 - 2030, USD Million
TABLE 28 US Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 29 US Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 30 US Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 31 US Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 32 Canada Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 33 Canada Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 34 Canada Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 35 Canada Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 36 Mexico Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 37 Mexico Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 38 Mexico Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 39 Mexico Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 40 Rest of North America Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 41 Rest of North America Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 42 Rest of North America Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 43 Rest of North America Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 44 Europe Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 45 Europe Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 46 Europe Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 47 Europe Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 48 Europe Cancer Market by Country, 2019 - 2022, USD Million
TABLE 49 Europe Cancer Market by Country, 2023 - 2030, USD Million
TABLE 50 Europe Inflammatory & Autoimmune Disorder Market by Country, 2019 - 2022, USD Million
TABLE 51 Europe Inflammatory & Autoimmune Disorder Market by Country, 2023 - 2030, USD Million
TABLE 52 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 53 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 54 Europe Bispecific Antibodies Market by Country, 2019 - 2022, USD Million
TABLE 55 Europe Bispecific Antibodies Market by Country, 2023 - 2030, USD Million
TABLE 56 Germany Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 57 Germany Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 58 Germany Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 59 Germany Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 60 UK Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 61 UK Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 62 UK Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 63 UK Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 64 France Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 65 France Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 66 France Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 67 France Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 68 Russia Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 69 Russia Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 70 Russia Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 71 Russia Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 72 Spain Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 73 Spain Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 74 Spain Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 75 Spain Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 76 Italy Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 77 Italy Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 78 Italy Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 79 Italy Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 80 Rest of Europe Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 81 Rest of Europe Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 82 Rest of Europe Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 83 Rest of Europe Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 84 Asia Pacific Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 85 Asia Pacific Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 86 Asia Pacific Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 87 Asia Pacific Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 88 Asia Pacific Cancer Market by Country, 2019 - 2022, USD Million
TABLE 89 Asia Pacific Cancer Market by Country, 2023 - 2030, USD Million
TABLE 90 Asia Pacific Inflammatory & Autoimmune Disorder Market by Country, 2019 - 2022, USD Million
TABLE 91 Asia Pacific Inflammatory & Autoimmune Disorder Market by Country, 2023 - 2030, USD Million
TABLE 92 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 93 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 94 Asia Pacific Bispecific Antibodies Market by Country, 2019 - 2022, USD Million
TABLE 95 Asia Pacific Bispecific Antibodies Market by Country, 2023 - 2030, USD Million
TABLE 96 China Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 97 China Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 98 China Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 99 China Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 100 Japan Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 101 Japan Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 102 Japan Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 103 Japan Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 104 India Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 105 India Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 106 India Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 107 India Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 108 South Korea Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 109 South Korea Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 110 South Korea Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 111 South Korea Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 112 Singapore Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 113 Singapore Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 114 Singapore Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 115 Singapore Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 116 Malaysia Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 117 Malaysia Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 118 Malaysia Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 119 Malaysia Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 120 Rest of Asia Pacific Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 121 Rest of Asia Pacific Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 122 Rest of Asia Pacific Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 123 Rest of Asia Pacific Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 124 LAMEA Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 125 LAMEA Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 126 LAMEA Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 127 LAMEA Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 128 LAMEA Cancer Market by Country, 2019 - 2022, USD Million
TABLE 129 LAMEA Cancer Market by Country, 2023 - 2030, USD Million
TABLE 130 LAMEA Inflammatory & Autoimmune Disorder Market by Country, 2019 - 2022, USD Million
TABLE 131 LAMEA Inflammatory & Autoimmune Disorder Market by Country, 2023 - 2030, USD Million
TABLE 132 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 133 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 134 LAMEA Bispecific Antibodies Market by Country, 2019 - 2022, USD Million
TABLE 135 LAMEA Bispecific Antibodies Market by Country, 2023 - 2030, USD Million
TABLE 136 Brazil Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 137 Brazil Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 138 Brazil Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 139 Brazil Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 140 Argentina Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 141 Argentina Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 142 Argentina Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 143 Argentina Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 144 UAE Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 145 UAE Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 146 UAE Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 147 UAE Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 148 Saudi Arabia Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 149 Saudi Arabia Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 150 Saudi Arabia Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 151 Saudi Arabia Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 152 South Africa Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 153 South Africa Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 154 South Africa Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 155 South Africa Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 156 Nigeria Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 157 Nigeria Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 158 Nigeria Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 159 Nigeria Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 160 Rest of LAMEA Bispecific Antibodies Market, 2019 - 2022, USD Million
TABLE 161 Rest of LAMEA Bispecific Antibodies Market, 2023 - 2030, USD Million
TABLE 162 Rest of LAMEA Bispecific Antibodies Market by Indication, 2019 - 2022, USD Million
TABLE 163 Rest of LAMEA Bispecific Antibodies Market by Indication, 2023 - 2030, USD Million
TABLE 164 Key Information – Amgen, Inc.
TABLE 165 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 166 Key Information – Pfizer, Inc.
TABLE 167 Key Information – Akeso, Inc.
TABLE 168 Key information –Johnson & Johnson
TABLE 169 key Information – Taisho Pharmaceuticals Holding Co., Ltd.
TABLE 170 Key Information – Immunocore Holdings plc
TABLE 171 Key Information – GlaxoSmithKline PLC
TABLE 172 Key Information – Novartis AG
TABLE 173 Key Information – Allergan PLC